Defense Health Agency Issues New Authority to GlobalMed

Authority to Operate enables all Defense Health Agency locations to purchase and utilize GlobalMed's Virtual Health Technologies

GlobalMed, an international provider of telehealth solutions, today announced that its industry leading virtual health platform has earned the Defense Health Agency (DHA) Authority to Operate (ATO) on the U.S. Department of Defense (DoD) DHA Medical Community of Interest (Med COI) network.

GlobalMed’s virtual health solutions are the first synchronous clinical virtual health technologies awarded an ATO. This much coveted certification enables GlobalMed to integrate their virtual health platform including carts, medical devices, software, and applications directly with the DHA’s Med COI network, making their solutions available to integrate with MHS Genesis, the new patient-centric enterprise system designed to provide a single, continuous record of care for all DOD beneficiaries. In addition to providing medical care on the battlefield and at bases overseas (as well as on ships) DHA’s network includes 721 military treatment facilities and 174,000 health care personnel, which provide health services to approximately 9.6 million beneficiaries.

“It has always been a personal priority to increase health care access for the members and families of the Army, Navy, Air Force, Marines, Space Force and Coast Guard,” said Joel E. Barthelemy, CEO and Vice Chairman of GlobalMed and a Marine Corps Reserve Veteran. “The Department of Defense is a huge healthcare provider and network security is a high priority. GlobalMed is committed to every aspect of security and compliance throughout our applications having recently completed our SOC 2 Type 2 examination with even more stringent security attestations on our road map. Our commitment to delivering unmatched performance, security and scalability extends beyond our government clients to those in the commercial enterprise space, giving physician groups and non-government hospitals an added measure of reassurance.”

DHA selected GlobalMed for its HIPAA-compliant virtual telemedicine platform that seamlessly and securely connects healthcare professionals and patients, regardless of location. GlobalMed is also the telehealth provider for the White House Medical Unit and has deployed their solutions across the VA hospitals and extension centers, and other U.S. Departments and Agencies.

SourceGlobalMed

Hot this week

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."